FDA News Digest February 28, 2005 _______________________________________________________ IN THIS WEEK'S ISSUE -- Illegal SciFit Procut and Thermogen II Dietary Supplements Seized -- Recalls/Market Withdrawals -- Recent Speeches -- Public Meetings _______________________________________________________ Illegal SciFit Procut and Thermogen II Dietary Supplements Seized U.S. marshals have seized $13,500 worth of SciFit and Thermogen II dietary supplements from Pennsylvania-based ATF Fitness Products, Inc. FDA determined that the products either contained banned ephedrine alkaloids or claimed to contain ephedrine or ephedrine alkaloids but did not. By law, such adulterated or misbranded products are prohibited. http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01342.html _______________________________________________________ RECALLS/MARKET WITHDRAWALS The following products are being recalled for the reasons shown. Go to the linked page for more information. Merita Autumn Grain Bread; 20-oz. (possible contamination with small pieces of plastic) http://www.fda.gov/oc/po/firmrecalls/interstate02_05.html Heng Tai Shi Crunch Snack (undeclared peanuts) http://www.fda.gov/oc/po/firmrecalls/murray02_05.html Fay's Foods sandwiches and salads (possible Listeria monocytogenes contamination) http://www.fda.gov/oc/po/firmrecalls/fay02_05.html For a list of recalls, market withdrawals, and safety alerts involving FDA-regulated products from the last 60 days, go to http://www.fda.gov/opacom/7alerts.html To access the RSS feed of FDA recalls information, go to http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml _______________________________________________________ RECENT SPEECHES FDA Acting Commissioner Lester M. Crawford, D.V.M., before the National Cancer Advisory Board; subject: announcement of the NCI/FDA Research and Regulatory Review Fellowship Program (Feb. 16) http://www.fda.gov/oc/speeches/2005/cancerab0216.html To view an archive of past speeches by FDA officials, go to http://www.fda.gov/speeches/speechli.htm _______________________________________________________ PUBLIC MEETINGS March 3-4 -- FDA Cellular, Tissue and Gene Therapies Advisory Committee; under discussion: cellular therapies for repair and regeneration of joint surfaces (Rockville, Md.) http://www.fda.gov/oc/advisory/accalendar/2005/cber12389dd03030405amd.html March 3-4 -- FDA Oncologic Drugs Advisory Committee; under discussion: application for new drug Combidex and treatments for prostate cancer and lung cancer (Gaithersburg, Md.) http://www.fda.gov/oc/advisory/accalendar/2005/cder12542dd03030405.html March 11 -- FDA Antiviral Drugs Advisory Committee; under discussion: proposed treatment for hepatitis B (Gaithersburg, Md.) http://www.fda.gov/oc/advisory/accalendar/2005/cder12531d031105.html April 27-28 -- 11th Annual FDA Science Forum; includes a free public session on personalizing your healthcare, and scientific sessions on nanotechnology, animal models, cancer diagnosis/treatment, risk management, and other topics (Washington, D.C.) http://www.cfsan.fda.gov/~frf/forum05/sxsf05pr.html For a list of FDA meetings, seminars, and other public events, go to http://www.fda.gov/opacom/hpmeetings.html _______________________________________________________ Thanks for subscribing to FDA News Digest. Our next posting will be March 7. To subscribe to or unsubscribe from this list, go to http://list.nih.gov/cgi-bin/wa?SUBED1=fda-newsdigest-l&A=1
